MSB 0.36% $1.39 mesoblast limited

2023 The Final Countdown, page-1210

  1. 7,872 Posts.
    lightbulb Created with Sketch. 1354
    You get lot more evidence from an RCT than anything you listed in your post.

    I disagree with whytee, I don't think it's 50/50, likely lower.

    It may get through. But the FDA spelled out clearly what they thought was necessary. MSB jumped through hoops to not do what they wanted.

    Will the FDA ask why they didn't do an RCT? Of course. And what will be their answer?

    Keen to find out soon
    Last edited by DocMcstuffins: 03/07/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.